Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great number of patients helpless. It is a complex disease and still a major challenge for the …
JC Monboisse, JB Oudart, L Ramont… - … et Biophysica Acta (BBA …, 2014 - Elsevier
Background Tumor microenvironment is a complex system composed of a largely altered extracellular matrix with different cell types that determine angiogenic responses and tumor …
K Jin, NB Pandey, AS Popel - Breast Cancer Research, 2018 - Springer
Background Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and incurable disease. Numerous studies have been conducted to seek molecular targets to …
Tumour and organ microenvironments are crucial for cancer progression and metastasis. Crosstalk between multiple non-malignant cell types in the microenvironments and cancer …
Angiogenesis is naturally balanced by many pro-and anti-angiogenic factors while an imbalance of these factors leads to aberrant angiogenesis, which is closely associated with …
Background Tamoxifen (TAM) is widely used in the chemotherapy of breast cancer and as a preventive agent against recurrence after surgery. However, extended TAM administration …
Highlights•Systems biology approaches support drug development efforts.•Models of angiogenesis aid in testing anti-angiogenic therapeutic strategies.•Models provide novel …
C Hu, X Chen, Y Huang, Y Chen - Apoptosis, 2018 - Springer
In this study, a peptide–peptide co-administration therapy between hybrid peptide kla-TAT and cationic anticancer peptide HPRP-A1 was designed to increase the anticancer activity …
E Lee, SJ Lee, JE Koskimaki, Z Han, NB Pandey… - Scientific reports, 2014 - nature.com
Metastasis is the main cause of mortality in cancer patients. Though there are many anti- cancer drugs targeting primary tumor growth, anti-metastatic agents are rarely developed …